2022 annual financial data
UroGen Pharma 2022 Operating margin
Direct answer
Operating margin was -122.82%.
Operating income was -79,041,000 USD and net income was -109,783,000 USD.
Operating cash flow was -87,559,000 USD.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 64,357,000 USD
- Operating income
- -79,041,000 USD
- Net income
- -109,783,000 USD
- Operating cash flow
- -87,559,000 USD